Expert Opinion on Therapeutic Patents

Title Publication Date Language Citations
Carbonic anhydrase inhibitors and their therapeutic potential2000/05/01English447
Antiglaucoma carbonic anhydrase inhibitors: a patent review2013/04/30English249
Applications of carbonic anhydrase inhibitors and activators in therapy2002/02/01English228
Diuretics with carbonic anhydrase inhibitory action: a patent and literature review (2005 – 2013)2013/03/14English223
Anticancer carbonic anhydrase inhibitors: a patent review (2008 – 2013)2013/05/15English220
Antiobesity carbonic anhydrase inhibitors: a literature and patent review2013/04/22English216
Schiff bases in medicinal chemistry: a patent review (2010-2015)2016/11/07English207
Silver and its application as an antimicrobial agent2005/02/01English204
Sulfonamides: a patent review (2008 – 2012)2012/06/15English195
Anti-infective carbonic anhydrase inhibitors: a patent and literature review2013/03/14English186
Quinazoline and quinazolinone as important medicinal scaffolds: a comparative patent review (2011–2016)2018/02/05English158
Anticonvulsant/antiepileptic carbonic anhydrase inhibitors: a patent review2013/03/21English157
Solid lipid nanoparticles: a review on recent perspectives and patents2020/01/31English155
Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008–2018)2018/08/09English154
5-Lipoxygenase inhibitors: a review of recent developments and patents2010/02/24English147
Recent advances in therapeutic chalcones2004/12/01English146
Urease inhibitors as potential drugs for gastric and urinary tract infections: a patent review2011/04/04English143
Therapeutic effects of EGCG: a patent review2016/06/29English142
Carbonic anhydrase inhibitors and activators and their use in therapy2006/11/22English142
Piperazine derivatives for therapeutic use: a patent review (2010-present)2016/05/31English141
Coumarin-based drugs: a patent review (2008 – present)2012/04/01English141
Modulation of carbonic anhydrase activity and its applications in therapy2004/05/01English138
Recent developments in CCR2 antagonists2009/03/01English138
Deuterated drugs: where are we now?2014/07/29English136
Carbonic anhydrase inhibitors in the treatment and prophylaxis of obesity2003/10/01English132
The development of novel therapies for rheumatoid arthritis2008/06/19English128
Taxane anticancer agents: a patent perspective2015/12/10English127
GPR119 agonists for the treatment of type 2 diabetes2009/09/28English125
Novel sulphonamide derivatives for the treatment of cancer2000/11/01English121
Betulinic acid and its derivatives: a patent review (2008 – 2013)2014/06/07English120